Kim Cocks
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- Cancer survivorship and care
- Bone health and treatments
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
- Oncology 32
- Cancer survivorship and care 14
- Cancer Treatment and Pharmacology 9
- Hematology 21
- Multiple Myeloma Research and Treatments 18
- Co-authors
- Galina Velikova (18 shared papers)Julia Brown (7 shared papers)Madeleine King (16 shared papers)Peter Fayers (4 shared papers)David Torgerson (4 shared papers)Gilberto de Castro (1 shared paper)Graham Jackson (7 shared papers)Gareth J. Morgan (7 shared papers)
- Journals
- Value in Health (19 papers)Blood (10 papers)Quality of Life Research (8 papers)European Journal of Cancer (7 papers)Journal of Clinical Oncology (4 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Kim Cocks
107 papers receiving 3.7k citations
Kim Cocks's Hit Papers
Peers
Comparison fields: 5 of 144
- Hematology 830
- Oncology 1.3k
- Otorhinolaryngology 89
- Genetics 213
- Periodontics 81
Countries citing papers authored by Kim Cocks
This map shows the geographic impact of Kim Cocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Cocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Cocks more than expected).
Fields of papers citing papers by Kim Cocks
This network shows the impact of papers produced by Kim Cocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Cocks. The network helps show where Kim Cocks may publish in the future.
Co-authors
The 25 scholars most cited alongside Kim Cocks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 479 | |
| 2 | First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial Hit paper breakdown → | 2010 | 407 |
| 3 | 2012 | 341 | |
| 4 | 2012 | 273 | |
| 5 | 2007 | 182 | |
| 6 | 2010 | 135 | |
| 7 | 2008 | 131 | |
| 8 | 2011 | 117 | |
| 9 | 2017 | 95 | |
| 10 | 2022 | 80 | |
| 11 | 2023 | 75 | |
| 12 | 2015 | 62 | |
| 13 | 2019 | 60 | |
| 14 | 2015 | 59 | |
| 15 | 2016 | 59 | |
| 16 | 2018 | 52 | |
| 17 | 2008 | 49 | |
| 18 | 2013 | 45 | |
| 19 | 2018 | 41 | |
| 20 | 2012 | 41 |
About Kim Cocks
Kim Cocks is a scholar working on Oncology, Hematology, Economics and Econometrics, Molecular Biology and Genetics, having authored 114 papers that have together received 3.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (18 papers), Cancer survivorship and care (14 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers), Cancer Treatment and Pharmacology (9 papers), Protein Degradation and Inhibitors (7 papers), Economic and Financial Impacts of Cancer (7 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Hematology (830 citations), Oncology (1.3k citations), Otorhinolaryngology (89 citations), Genetics (213 citations) and Periodontics (81 citations). Kim Cocks has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Galina Velikova, Julia Brown, Madeleine King, Peter Fayers, David Torgerson, Gilberto de Castro, Graham Jackson, Gareth J. Morgan, Faith E. Davies and Mark T. Drayson. Their work appears in journals such as Value in Health, Blood, Quality of Life Research, European Journal of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.